Concepedia

Graham J. Warrellow

GJ

Statistics

Publications

17

Citations

543

H-Index

14

Active since

1987

Affiliations

Almirall (Spain)(Current)

UCB Pharma (United Kingdom)

Cell Technology (China)

Graham J. Warrellow is an author at Almirall (Spain) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1987–2007

17

Publications

17

The inhibition of antigen‐induced eosinophilia and bronchoconstriction by CDP840, a novel stereo‐selective inhibitor of phosphodiesterase type 4

B. Hughes, D. Howat, H. Lisle et al. · British Journal of Pharmacology · 1996 · 95 citations · Full text

, , +15

CDP840. A prototype of a novel class of orally active anti-Inflammatory phosphodiesterase 4 inhibitors

Rakki P. Alexander, Graham J. Warrellow, Michael A. W. Eaton et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 57 citations · Full text

, , +9

PDE 4 inhibitors: the use of molecular cloning in the design and development of novel drugs

Bernadette Hughes, Raymond J. Owens, Martin J Perry et al. · Drug Discovery Today · 1997 · 48 citations

, , +15

Synthesis of the isoindolobenzazepine alkaloid lennoxamine

Christopher J. Moody, Graham J. Warrellow · Tetrahedron Letters · 1987 · 46 citations

, , +4

Racemic and chiral sulfoxides as potential prodrugs of the COX-2 inhibitors Vioxx® and Arcoxia®

Francisco Caturla, M. Amat, Raquel F. Reinoso et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 36 citations · Full text

, , +5

1–5 of 17